NovoSeven RT

Generic Name: coagulation factor viia (Intravenous route)

koh-a-gyoo-LAY-shun FAK-tor SEV-en A

Intravenous route(Powder for Solution)

Serious arterial and venous thrombotic and thromboembolic adverse events, including fatalities, are associated with the use of coagulation factor VIIa when used outside labeling indications. Patients should be advised and monitored on the signs/symptoms of thrombotic and thromboembolic events .

Commonly used brand name(s)

In the U.S.

• Novoseven


• NovoSeven RT

Available Dosage Forms:

• Powder for Solution

Therapeutic Class: Hemostatic

Uses For NovoSeven RT

Factor VIIa is used to treat and prevent bleeding episodes in patients with Hemophilia A or B who have formed antibodies against other clotting proteins (e.g., Factor VIII or Factor IX) that help bleeding to stop. It is also used to treat or prevent bleeding in patients with acquired hemophilia or congenital Factor VII deficiency.

Factor VIIa is a man-made protein produced to replicate the naturally occurring activated factor VII (factor VIIa) in the body. It is used to stop bleeding of injuries for patients with hemophilia by helping the blood to clot.

Factor VIIa is to be administered only by or under the supervision of your doctor or other health care professional.

Before Using NovoSeven RT

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of Factor VIIa in children.

Geriatric

Adequate and well-controlled studies have not been done on the relationship of age to the effects of Factor VIIa in geriatric patients.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:

• Blood clots or a history of medical problems caused by blood clots or


• Heart disease or


• Infection or


• Injury (crush)—These conditions may increase the risk of developing blood clots.

Proper Use of coagulation factor viia

This section provides information on the proper use of a number of products that contain coagulation factor viia. It may not be specific to NovoSeven RT. Please read with care.

A nurse or other trained health professional will give you this medicine. This medicine is given through a needle placed in one of your veins.

Precautions While Using NovoSeven RT

It is very important that your doctor check your progress closely while you are receiving this medicine to make sure it is working properly. Blood tests may be needed to check for unwanted effects.

If you notice early signs of a hypersensitivity reaction such as hives, skin rash, tightness of the chest or wheezing, lightheadedness or dizziness, notify your physician immediately.

This medicine may increase your chance of having blood clotting problems. Tell your doctor right away if you have sudden or severe headache, problems with vision or speech, chest pain, shortness of breath, or numbness or weakness while you are receiving this medicine.

NovoSeven RT Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

More common

• Bleeding problems


• fever


• high blood pressure


• joint or muscle pain and/or stiffness

Less common or rare

• Bloating or swelling of the face, hands, lower legs, and/or feet


• bluish color of the hands or feet


• blurred vision


• changes in facial color


• chest pain


• chills


• cold sweats


• confusion


• continuing thirst


• cough


• dizziness


• excessive sweating


• faintness


• fast heartbeat


• hives and/or itching


• large flat blue or purplish patches on the skin


• lightheadedness when getting up from a lying or sitting position suddenly


• persistent bleeding or oozing from puncture sites or mucous membranes (bowel, mouth, nose, or urinary bladder)


• puffiness or swelling of the eyelids or around the eyes


• shakiness


• shortness of breath


• skin rash


• slow or irregular heartbeat (less than 50 beats per minute)


• slurred speech


• sneezing


• sore throat


• sudden decrease in the amount of urine


• swelling of the face, fingers, feet, and/or lower legs


• troubled breathing, tightness in the chest, and/or wheezing


• unusual tiredness or weakness


• weight gain (unusual)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare

• Burning or stinging at the injection site


• changes in the blood pressure or pulse rate


• drowsiness


• flushing (redness of the face)


• headache


• nausea or vomiting


• pinpoint red or purple spots on the skin

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: NovoSeven RT side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More NovoSeven RT resources

• NovoSeven RT Side Effects (in more detail)
• NovoSeven RT Use in Pregnancy & Breastfeeding
• NovoSeven RT Drug Interactions
• NovoSeven RT Support Group
• 0 Reviews for NovoSeven RT - Add your own review/rating

• NovoSeven RT Prescribing Information (FDA)


• NovoSeven RT injection Concise Consumer Information (Cerner Multum)


• NovoSeven RT Monograph (AHFS DI)


• NovoSeven RT MedFacts Consumer Leaflet (Wolters Kluwer)


• Novoseven MedFacts Consumer Leaflet (Wolters Kluwer)

Compare NovoSeven RT with other medications

• Factor VII Deficiency
• Hemophilia A
• Hemophilia B